ASSEMBLY, No. 1620

STATE OF NEW JERSEY

218th LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2018 SESSION

 


 

Sponsored by:

Assemblywoman  HOLLY T. SCHEPISI

District 39 (Bergen and Passaic)

Assemblywoman  VALERIE VAINIERI HUTTLE

District 37 (Bergen)

Assemblywoman  ANNETTE CHAPARRO

District 33 (Hudson)

 

 

 

 

SYNOPSIS

     Requires drug test specimens from drug abuse treatment clinics be analyzed by independent clinical laboratory.

 

CURRENT VERSION OF TEXT

     Introduced Pending Technical Review by Legislative Counsel.

  


An Act concerning drug testing by drug abuse treatment clinics and amending P.L.1971, c.128.

 

     Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

     1.    Section 4 of P.L.1971, c.128 (C.26:2G-34) is amended to read as follows:

     4.    a.  The clinics, regional centers, and outreach offices established [hereunder] pursuant to P.L.1971, c.128 (C.26:2G-31 et seq.) shall provide a complete program of medical and community services in connection with all aspects of the use and abuse of drugs and related problems, including, but not by way of limitation, the following:

     (1)   educational programs;

     (2)   confidential drug counseling;

     (3)   vocational guidance and job placement;

     (4)   psychiatric, psychological, and social case work services;

     (5)   induction and outreach services;

     (6)   24-hour telephone emergency capability;

     (7)   urine monitoring, in accordance with the provisions of subsection b. of this section;

     (8)   detoxification;

     (9)   methadone maintenance;

     (10)  individual and community prevention program;

     (11)  individual self-help and group therapy;

     (12)  referral services for in-patient treatment;

     (13)  all areas of treatment and addict rehabilitation;

     (14)  aftercare treatment; and

     (15)  probation services for the courts and correctional systems.

     b.    A clinic, regional center, or outreach office operating pursuant to P.L.1971, c.128 (C.26:2G-31 et seq.) shall arrange to have all specimens from required drug tests of its patients that are not analyzed by the State laboratory be analyzed by a clinical laboratory that is licensed pursuant to P.L.1975, c.166 (C.45:9-42.26 et seq.) and is not affiliated with the clinic, regional center, or outreach office, in accordance with regulations to be adopted by the commissioner pursuant to section 6 of P.L.1971, c.128 (C.26:2G-36).

(cf: P.L.1971, c.128, s.4)

 

     2.    This act shall take effect on the first day of the seventh month after the date of enactment, but the commissioner may take such anticipatory administrative action in advance thereof as shall be necessary for the implementation of this act.

STATEMENT

 

     This bill requires that drug test specimens from drug abuse treatment clinics be analyzed by the State laboratory or by an independent clinical laboratory.

     Specifically, the bill directs a drug abuse treatment clinic operating pursuant to P.L.1971, c.128 (C.26:2G-31 et seq.) to have all specimens from required drug tests of its patients that are not analyzed by the State laboratory be analyzed by a clinical laboratory that is licensed by the Department of Health pursuant to P.L.1975, c.166 (C.45:9-42.26 et seq.) and that is not affiliated with the drug abuse treatment clinic, in accordance with regulations to be adopted by the Commissioner of Human Services.